- Home
- FMBH vs AVBP Comparison
FMBH vs AVBP Comparison
Compare FMBH & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- AVBP
- Stock Information
- Founded
- FMBH 1865
- AVBP 2021
- Country
- FMBH United States
- AVBP United States
- Employees
- FMBH N/A
- AVBP N/A
- Industry
- FMBH Major Banks
- AVBP
- Sector
- FMBH Finance
- AVBP
- Exchange
- FMBH Nasdaq
- AVBP NYSE
- Market Cap
- FMBH 769.8M
- AVBP 617.4M
- IPO Year
- FMBH N/A
- AVBP 2024
- Fundamental
- Price
- FMBH $36.39
- AVBP $20.15
- Analyst Decision
- FMBH Hold
- AVBP Strong Buy
- Analyst Count
- FMBH 5
- AVBP 6
- Target Price
- FMBH $44.00
- AVBP $39.00
- AVG Volume (30 Days)
- FMBH 54.3K
- AVBP 158.1K
- Earning Date
- FMBH 04-30-2025
- AVBP 05-20-2025
- Dividend Yield
- FMBH 2.65%
- AVBP N/A
- EPS Growth
- FMBH 8.80
- AVBP N/A
- EPS
- FMBH 3.37
- AVBP N/A
- Revenue
- FMBH $321,695,000.00
- AVBP N/A
- Revenue This Year
- FMBH N/A
- AVBP $63.13
- Revenue Next Year
- FMBH $4.16
- AVBP N/A
- P/E Ratio
- FMBH $10.86
- AVBP N/A
- Revenue Growth
- FMBH 11.71
- AVBP N/A
- 52 Week Low
- FMBH $27.58
- AVBP $15.47
- 52 Week High
- FMBH $43.86
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- FMBH 64.52
- AVBP 51.13
- Support Level
- FMBH $35.15
- AVBP $18.84
- Resistance Level
- FMBH $36.82
- AVBP $21.79
- Average True Range (ATR)
- FMBH 1.05
- AVBP 1.12
- MACD
- FMBH 0.44
- AVBP 0.00
- Stochastic Oscillator
- FMBH 90.65
- AVBP 44.50
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.